Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BI

Beat Imhof — 18 Patents

RFResearch Development Foundation: 6 patents #31 of 362Top 9%
Merck: 6 patents #1,833 of 9,382Top 20%
BUBar-Ilan University: 3 patents #44 of 412Top 15%
UGUniversity Of Geneva: 3 patents #5 of 48Top 15%
LSLaboratoires Serono S.A.: 1 patents #38 of 105Top 40%
UGUniversite De Geneve: 1 patents #33 of 150Top 25%
Hoffmann-La Roche: 1 patents #1,850 of 3,238Top 60%
Sierne, CH: #1 of 1 inventorsTop 100%
Overall (All Time): #245,716 of 4,157,543Top 6%
18 Patents All Time
Beat Imhof has been granted 18 US patents while listed as an inventor at Research Development Foundation. The first was granted in 1996 and the most recent in March 2025. Beat Imhof ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list Beat Imhof in Sierne, CH.

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
12252472 Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer Arie Lev Gruzman, Paul Bradfield, Tamar Getter, Thomas Matthes, Hanoch Senderowitz 2025-03-18
12240820 Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer Arie Lev Gruzman, Paul Bradfield, Tamar Getter, Thomas Matthes, Hanoch Senderowitz 2025-03-04
11492333 Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer Arie Lev Gruzman, Paul Bradfield, Tamar Getter, Thomas Matthes, Hanoch Senderowitz 2022-11-08
10808026 Monoclonal Olfml-3 antibodies and uses thereof Marijana Miljkovic-Licina, Philippe Hammel 2020-10-20
10759857 JAM-C antibodies and methods for treatment of cancer Christiane Ody, Thomas Matthes, Carmen Donate 2020-09-01
10385129 JAM-C antibodies and methods for treatment of cancer Christiane Ody, Thomas Matthes, Carmen Donate 2019-08-20
9803014 JAM-C antibodies and methods for treatment of cancer Christiane Ody, Thomas Matthes, Carmen Donate 2017-10-31
9096662 Methods and compositions for modulation of Olfml3 mediated angiogenisis Marijana Miljkovic-Licina, Philippe Hammel 2015-08-04
8663637 Methods and compositions for modulation of Olfml3 mediated angiogenesis Marijana Miljkovic-Licina, Philippe Hammel 2014-03-04
8143056 Vascular adhesion molecules and modulation of their function Michel Aurrand-Lions 2012-03-27
8093010 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer Michel Aurrand-Lions 2012-01-10
8007797 Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use Pierre-Yves Dietrich, Mirna Tenan, Michel Aurrand-Lions 2011-08-30
7790863 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer Michel Aurrand-Lions 2010-09-07
7670826 Confluence regulated adhesion molecules useful in modulating vascular permeability Michel Aurrand-Lions 2010-03-02
7642341 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer Michel Aurrand-Lions 2010-01-05
7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability Michel Aurrand-Lions 2008-07-01
7033794 Basolateral sorting signal and inhibitors thereof Bernhard M. Wehrle-Haller 2006-04-25
5538725 Method of inhibiting metastasis by anti-.alpha.6-integrin-antibodies 1996-07-23